G.N.TECH Venture Capital

Investment decisions are led by Co-CEOs Chung-Hee Hong and Jun-Kyu Kang, who founded the firm in 2000. They are supported by three senior managing directors — Sung-Won Park, Sun-Kyung Lee, and Min-Sub Song — and a deal team comprising a director and two team leaders. The firm's website lists eight investment professionals across seniority levels, indicating a flat hierarchy where the co-CEOs remain directly involved in pipeline and portfolio decisions.

G.N.TECH invests from seed and early stage through to pre-IPO, with a broad mandate covering internet and mobile software, ICT and industrial technology, biotechnology and healthcare, and consumer and cosmetics. Its website states it captures early-stage startups and supports them through growth and scale-up. The strategy is built on direct equity investments, and the firm does not market itself as a fund-of-funds or LP in other VC vehicles.

The firm operates a domestic origination model rooted in 25 years of South Korean network-building. Its website emphasizes trust and experience, and its portfolio of 290 companies suggests a high-volume, relationship-driven sourcing funnel rather than thematic, research-led outbound targeting. The co-CEOs' longevity in the Seoul ecosystem provides access to founders, university labs, and government-backed startup programs.

G.N.TECH's website lists over 80 portfolio companies that have completed IPOs, including Kakao, Café24, Alteogen, HLB, and APR Corp. This IPO volume is central to its value proposition for limited partners, functioning as a repeatable distribution channel for early-stage Korean technology. The firm also records a smaller number of M&A exits, including AquaStar and Fresh Easy (formerly Doctor Kitchen).

G.N.TECH is an independent venture capital firm, not a single-family office or multi-family office. It raises discretionary funds from external limited partners and has cumulatively managed ₩435.7 billion across 15 funds since 2000. There is no disclosed connection to a specific family fortune or captive capital source.

The firm's disclosed model is direct investing into portfolio companies. There is no indication on its website or in its public materials that it makes fund commitments to other VC or PE managers. G.N.TECH markets itself as a partner that invests directly alongside entrepreneurs from early stage through IPO.

The firm organizes its portfolio into four public categories: Internet, Mobile, Software and FinTech; ICT and Industrial; Bio and Healthcare; and Cosmetic, Consumer and Contents. Within those buckets, its website lists confirmed positions in enterprise software (Kakao, Café24), fintech (Viva Republica/Toss not confirmed directly, but fintech is tagged), semiconductors and materials (HFR, GCT Semiconductor), medical devices and biopharma (Alteogen, Caregen, Humasis), and consumer brands (Musinsa, APR Corp).